Lowering the Cost of Insulin Could Be Deadly

> If the cost of insulin is capped on its own, insulin will be more likely to jump in front of SGLT2 inhibitors and GLP-1 receptor agonists in treatment plans. That will mean more disease, more disability, and more death from diabetes.

So all drugs should equally be cheaper, the point still stands.